文献速递炎症性肠病

炎症性肠病诊断前后的合并症负担研究

Comorbidity before and after a diagnosis of inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2021-06-22

基于马尼托巴大学IBD流行病学数据库的队列研究,纳入1984至2018年所有IBD患者及匹配对照,评估Charlson合并症指数中12种组分疾病在IBD诊断前后的相对率和风险比。结果显示IBD患者在诊断前即有心血管、外周血管、慢性肺病、结缔组织/风湿病、肾病、肝病、消化性溃疡和癌症的相对率升高,诊断后所有合并症均增加,且除糖尿病外合并症诊断年龄均较对照更年轻。

要点

  • IBD患者诊断前多种合并症相对率已升高,提示合并症负担先于IBD诊断。
  • IBD诊断后所有评估的合并症均增加,除糖尿病外诊断年龄均较对照更年轻。
  • 克罗恩病患者痴呆风险增加及截瘫/偏瘫关联为意外发现,需关注。

核心结论

  • IBD患者合并症负担高于非IBD人群,优化管理计划应评估几乎涉及所有器官系统的合并症。

研究设计与样本

  • 基于马尼托巴大学IBD流行病学数据库的队列研究,纳入1984年4月1日至2018年3月31日所有IBD患者及匹配对照,检索门诊索赔和出院摘要中的Charlson合并症指数组分诊断码,评估12种疾病。

主要发现

  • 心血管疾病、外周血管疾病、慢性肺病、结缔组织病/风湿病、肾病、肝病、消化性溃疡病和癌症在IBD诊断前的相对率均较对照升高。
  • IBD诊断后所有合并症均增加。
  • 克罗恩病患者痴呆的风险比增加,为值得关注的新发现;截瘫/偏瘫的关联出乎意料。
  • 除糖尿病外,所有合并症的诊断年龄在IBD患者中均较对照更年轻。

临床怎么用

  • IBD患者管理应包含对其他器官系统合并症的评估,而不仅限于肠道疾病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Comorbidity is an important predictor of how disease course in inflammatory bowel (IBD) evolves. AIMS: To determine pre-diagnosis relative rates (RR) and post-diagnosis hazard ratios (HR) of component diseases of the Charlson Comorbidity Index (CCI) in a cohort study of persons with IBD. METHODS: The University of Manitoba IBD Epidemiology Database includes all Manitobans with IBD from 1 April 1984 through 31 March 2018 and matched controls. All outpatient physician claims and hospital discharge abstracts were searched for diagnostic codes for CCI component diseases. Some diseases were collapsed into one group such that we assessed 12 conditions. We report the RR of these conditions prior to IBD and the incidence of these diagnoses after IBD. Using Cox proportional hazards regression we report post-diagnosis HR. Confidence intervals were adjusted for Bonferroni correction. RESULTS: The RR of cardiovascular diseases, peripheral vascular diseases, chronic pulmonary diseases, connective tissue disease/rheumatic diseases, renal disease, liver diseases, peptic ulcer disease, and cancer were all increased prior to diagnoses of IBD compared to controls. All comorbidities were increased post IBD diagnosis. The increased HR for dementia in persons with Crohn's disease was a concerning novel finding. The increased association with paraplegia/hemiplegia was unexpected. For all comorbidities, except diabetes, the age at diagnosis was younger in IBD than controls. CONCLUSIONS: Persons with IBD have a higher comorbidity burden than persons without IBD. Optimal care plans for persons with IBD should include an assessment for other comorbidities that include just about every other organ system.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Bernstein CN, Nugent Z, Shaffer S, et al. Comorbidity before and after a diagnosis of inflammatory bowel disease. Aliment Pharmacol Ther. 2021. PMID: 34156724. doi:10.1111/apt.16444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。